Chargement
Health & Life Sciences · INPI / RNE, INSEE Sirene, BODACC
| # | Company | City | Revenue | Headcount | Fiscal year |
|---|---|---|---|---|---|
| 1 | COURBEVOIE | 999.2 M EUR | 2024 | ||
| 2 | LYON | 690.6 M EUR | 2023 | ||
| 3 | ANNECY | 599.4 M EUR | 2024 | ||
| 4 | CLERMONT-FERRAND | 516.4 M EUR | 2023 | ||
| 5 | NEUILLY-SUR-SEINE | 505 M EUR | 2024 | ||
| 6 | VILLEPINTE | 499.8 M EUR | 2024 | ||
| 7 | COURBEVOIE | 495.5 M EUR | 2024 | ||
| 8 | LES ULIS | 492.1 M EUR | 2024 | ||
| 9 | SIGNES | 466.1 M EUR | 2024 | ||
| 10 | RUEIL-MALMAISON | 457.7 M EUR | 2024 |
This page lists 333 companies in the Drugs (pharmaceutical) sector (Health & Life Sciences group) registered in France. The revenue ranking uses the latest fiscal year filed with INPI / RNE, INSEE Sirene, BODACC, converted to euros. The full list, filterable by name, headcount or website, exports to Excel with contact details and breakdowns.
The table shows the top 10 companies by revenue, in public access. Of the 333 companies in scope, 219 publish revenue, for 18.84 bn EUR combined and a median revenue of 27.5 M EUR. The full list and the Excel export come with an account.